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Improved detection of weak,
clinically significant antibodies by
supplementation of polyethylene 
glycol with a low-ionic solution
K.S. LOW,Y-W. LIEW,AND P.M. BRADLEY
A comparative study of 164 serum samples was carried out to deter-
mine the specificity and sensitivity of the indirect antiglobulin test
(IAGT) in three different formulations: physiologic saline, low-ionic
solution (RAM), and RAM supplemented with polyethylene glycol
(PEG). Serum samples containing mostly weak antibodies (anti-D, -C,
-E, -c, -Jka, -Fya, -K, -S, -Lea, -Lua, -M, -Cob, -P1, -I, and -Kn
a) were used in
a 10-minute IAGT in which PEG-IAGTs were compared with saline-
IAGTs and RAM-IAGTs. With the exception of anti-P1, anti-I, and an
anti-Lea, PEG-IAGTs detected all the antibodies tested compared with
72.3% and 77.4% for saline-IAGTs and RAM-IAGTs, respectively. The
end-point titers of at least 82% of antibodies detected by PEG-IAGTs
were 1–3 dilutions higher than those by saline- and RAM-IAGTs. When
specificity of PEG-IAGTs was tested using 268 randomly selected,
fresh (< 1 day old) blood samples, PEG-IAGT detected 11 out of 268
samples as positive compared with 7 out of 268 by both saline-IAGTs
and RAM-IAGTs. The four antibodies that were not detected were
identified as anti-D, anti-E, anti-Bga, and an autoantibody known pre-
viously to be only reactive with papain-pretreated red cells. No non-
specific reactions were detected by PEG-IAGTs and no hemolysis was
evident in any of the IAGTs. PEG-IAGTs were more sensitive than
saline- and RAM-IAGTs. PEG-IAGTs detected all weak, clinically signif-
icant antibodies as well as four antibodies that were otherwise unde-
tected by saline-IAGT or RAM-IAGT. The overall sensitivity of the PEG-
IAGT was 96.3% compared with 84.1% and 73.2% for the RAM- and
saline-IAGT, respectively. Immunohematology 1998;14:68–71.
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Low-ionic-strength saline (LISS) is routinely used in
the indirect antiglobulin test (IAGT) in immunohematol-
ogy laboratories. Recently, several reports 1–5 in the liter-
ature have shown that the sensitivity of the IAGT incor-
porating low-ionic solutions or other potentiating agents
(albumin, enzyme, or polybrene) could be improved fur-
ther by substituting these potentiators with a polyethy-
lene glycol (PEG) solution. Our study with the incorpo-
ration of a commercially available low-ionic solution
(RAM) in the IAGT has demonstrated similar results with
an effective reduction in incubation time from 30 to 10
minutes without compromising the sensitivity of the
IAGT.6 This study aimed to further enhance the sensitiv-
ity of the RAM-IAGT by supplementing RAM with PEG
and comparing the results with the saline-IAGT and
RAM-IAGT. The effect of whether PEG causes red cell
hemolysis in the presence of complement,as reported in
the literature,7 also was determined using 268 samples
of randomly selected fresh blood samples.
Materials and Methods
Sera and red blood cells
Fresh sera and sera known to contain weak antibod-
ies (reaction score of 5 or less in saline or by LISS-IAGT)
were obtained from the Victoria Red Cross Blood
Service, Royal Melbourne Hospital in Victoria, and the
Queensland Red Cross Blood Service,all in Australia.One
red cell panel (Abtect III™, CSL Ltd.,Victoria,Australia)
was used throughout this study.
Antibody reactivity
Antibody detection was carried out by IAGT using
164 serum samples (Victoria and Queensland Red Cross
Blood Banks) known to contain weak antibodies of the
following specificities: anti-D, -C, -E, -c, -Jka, -Fya, -K, -S, -Lea,
-Lua, -M, -Cob, -P1, -I, and -Kn
a. For antibody titration, sam-
ples were diluted with a 1% bovine albumin solution in
phosphate-buffered saline before testing. The ability of
various reaction media to determine specificity by
IAGTs was performed using 268 randomly selected fresh
clotted blood samples (Royal Melbourne Hospital and
the Queensland Red Cross Blood Service).
IAGT 
IAGTs were performed using 60µL of serum, 30µL of
red blood cells (RBCs) I (R1R1) and II (R2R2) of a 3% RBC
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panel (Abtect III,CSL Ltd.),and 60µL of either saline (imi-
dazole-buffered saline [IBS], CSL Ltd.), low-ionic solution
(Rapid Antibody Medium [RAM], CSL Ltd.) or RAM sup-
plemented with PEG (CSL Ltd.).The tubes were incubat-
ed for 10 minutes at 37°C (the manufacturer’s recom-
mendations for RAM; for saline IAGT, they served as a
baseline only).After incubation, all tubes were washed ×
4 with saline and 60µL of either a polyclonal anti-IgG or
polyclonal/monoclonal anti-IgG,C3d anti-human globu-
lin (AHG) reagent (CSL Ltd.) was added. All negative
results were validated with AHG Control Cells (CSL Ltd.).
Specificity and sensitivity
Both the ability to determine specificity and the sen-
sitivity of the saline-IAGT, the RAM-IAGT, and the PEG-
IAGT were calculated using the following formulae:
specificity = (Tn/[Tn + Fp]) × 100; sensitivity = (Tp/[Tp
+ Fn]) × 100, where Tn = true negative, Fp = false posi-
tive,Tp = true positive, and Fn = false negative.
Results
When a PEG solution was added to a serum sample,
the mixture immediately turned cloudy, indicating a cer-
tain degree of protein precipitation had taken place.This
reaction did not seem to have an adverse effect on the
IAGT. In fact, this characteristic may be used as a distin-
guishing feature for determining whether a PEG solution
has been added in the tubes for a PEG-IAGT.
Saline-IAGT, RAM-IAGT, and PEG-IAGT results are
shown in Table 1.We tested 164 antibody-positive sam-
ples that encompassed 15 specificities.The total number
of each antibody detected by the IAGT in the presence
of either saline,RAM,or PEG in the reaction mixture was
determined.With the exception of anti-P1, anti-I, and one
anti-Lea, PEG-IAGTs detected all antibodies tested com-
pared with the saline- and RAM-IAGTs,which missed not
only anti-P1 and anti-I but also some of the other anti-
bodies (Jka, Fya, K, D, c, E, etc.).
When the titration scores of the antibodies (results
not shown) in the presence of the different test solu-
tions were compared,at least 95% of the scores obtained
with PEG-IAGTs were better than those obtained with
saline- and RAM-IAGTs; and at least 72% of RAM-IAGTs
scored better than saline-IAGTs (Table 2).
When the sensitivity of different additive solutions
was calculated from the results of the antibody-positive
samples, the PEG-IAGT had the highest sensitivity at
96.3% (Table 3),followed by the RAM-IAGT at 84.1%,and
the saline-IAGT at 73.2%.The “false negatives”were from
samples containing anti-P1, anti-I, and one anti-Le
a.With
the exception of anti-I, which was not detected at all
with Abtect III screening cells, all anti-P1 and an anti-Le
a
were positive by a saline immediate spin test.
When the specificity of the different additive solutions
was compared (Table 4),no additive solution gave a falsely
positive result (100% specific). A single myeloma sample
did not react in any IAGT (saline, RAM, or PEG solution).
Table 1. Antibody detection in different additive solutions by indirect 
antiglobulin test
Number of positive samples
Number in the presence of:
Anti- tested Saline RAM PEG
Jka 10 7 9 10
Fya 15 9 14 15
K 31 26 27 31
D 36 31 33 36
c 7 4 6 7
S 4 2 4 4
C 4 4 4 4
E 30 22 24 30
Lea 8 4 5 7
Lua 1 1 1 1
Kna 1 1 1 1
P1 4 0 0 0
Cob 1 1 1 1
M 11 8 9 11
I 1 0 0 0
Total 164 120 138 158
Table 2. Comparison of titration scores using different enhancement 
solutions
Percent of specimens* with a titration score greater than:
Method Saline RAM PEG
Saline – 5 2.5
RAM 72.5 – 2.5
PEG 95 95 –
* Total number of specimens tested = 164. All four anti-P1 and an anti-I that
did not react by IAGT are also included in the  calculation.
Table 3. Sensitivity of different additive solutions
Saline RAM PEG
Number of positive samples* 120/164 138/164 158/164
Sensitivity (%)† 73.2 84.1 96.3
* All antibody-positive samples, including anti-P1 and anti-I
† Sensitivity = (Tp/[Tp+Fn]) × 100, where Tp = True positive and
Fn = False negative
Table 4. Specificity of different additive solutions using 268 randomly 
selected serum samples
Samples                        No.
No. detected by:
Saline RAM PEG
Negative 257 0 0 0
Anti-K + c + E 1 1 1 1
Anti-D + C 1 1 1 1
Anti-Fya 1 1 1 1
Anti-D + E 1 1 1 1
Anti-c 1 1 1 1
Anti-D 3 2 2 3
Anti-E 1 0 0 1
Anti-Bga 1 0 0 1
Autoantibody 1 0 0 1
Total 268 7 7 11
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Although PEG has been reported to cause RBC
hemolysis in the presence of complement,7 hemolysis
was not observed in any of the IAGT tubes in the pres-
ence of either polyclonal anti-IgG or polyclonal/mono-
clonal anti-IgG,C3d reagents.
Four antibodies were not detected with saline- or
RAM-IAGTs but they were positively identified in PEG-
IAGTs.These were an anti-D, an anti-E, an anti-Bga, and
an autoantibody. Once again, these results demonstrat-
ed the superior sensitivity of the PEG-IAGT.
Discussion
When RAM was supplemented with PEG (RAM-
PEG), it potentiated antibody reactions in the IAGT by
enhancing the antibody titers by 1–3 dilutions when
compared with saline- or RAM-IAGT titers. The PEG-
supplemented RAM solution (RAM-PEG) also detected
“extra” antibodies that were missed by either saline- or
RAM-IAGTs. Antibody detection by saline-, RAM-, and
PEG-IAGTs were 100% specific with sensitivity ranging
from 96.3% for PEG-IAGTs to 84.1% for RAM-IAGTs and
73.2% for saline-IAGTs. No hemolysis was detected
when PEG was added to fresh serum samples nor with
AHG reagents with or without anti-C3d.The inclusion
of PEG in IAGTs did not induce any false results even
with an abnormally high protein sample from a myelo-
ma patient. Our results showed that RAM-PEG
increased detection of weak, potentially significant
antibodies but did not detect clinically insignificant
ones, such as anti-P1 and anti-I.
It is of interest that the initial publication2 recom-
mended the use of monospecific anti-IgG in preference
to polyspecific anti-IgG,C3d. This is to decrease the
incidence of false positives due to nonspecific uptake
of complement. In this study, no such false positives
were found using a polyspecific reagent. The reasons
for this discrepancy could be the use of a monoclonal
anti-C3d or the use of washed, commercially prepared
screening RBCs in the present study.
It has been well documented that monoclonal
reagents can be used at higher dilutions than polyclon-
al reagents due to the exquisitely defined specificity.8
This increase in specificity has led to more potent
reagents that do not crossreact nonspecifically. In light
of this work, it is possible that the use of monoclonal
anti-C3d reagents do not cause the high level of non-
specificity reported originally.2
A more probable explanation is the use of washed,
commercially produced RBCs in this study.These cells
are produced from fresh (< 7 days old) RBC concen-
trates and do not have the high levels of nonspecific
uptake of complement components reported in older
concentrates.9 The use of a PEG reagent in an anti-
body screening-only protocol would more likely result
in less falsely positive samples than a crossmatch pro-
tocol. This observation is supported by a recent
study10 in which the falsely positive rate using a PEG
reagent was less than that in an albumin and papain
protocol.
The use of a PEG reagent has been questioned by
some authors due to the perceived trade-off between
high sensitivity and specificity.7 This concern has not
been born out in this study, as there appears to be no
specificity penalty for the increased sensitivity. The
only possible increase in workload may be from the
increased sensitivity to antibodies such as anti-Bg,
which are of questionable clinical significance. A more
complete analysis of workload effects of incorporating
a PEG reagent actually resulted in a decrease in the
overall workload and an increase in productivity.5
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